Prostate cancer gene map points way to targeted drugs

The study suggests nearly nine in 10 patients with advanced prostate cancer could benefit from targeted treatments Scientists have unveiled a comprehensive genetic map of advanced prostate cancer, hailing it as the disease's "Rosetta Stone". The study, published in the journal Cell,, external shows that nearly nine in 10 men had gene mutations that could be targeted with drugs. The study was led i

[frothmouth]

“Scientists have unveiled a comprehensive genetic map of advanced prostate cancer, hailing it as the disease's "Rosetta Stone".”